EMA Refused: Human IGG1 monoclonal antibody specific for human interleukin-1 alpha XBiotech (human IgG1 monoclonal antibody specific for human interleukin-1 alpha) — XBiotech Germany GmbH

View source ↗

Summary

The EMA refused approval for a human IgG1 monoclonal antibody targeting interleukin-1 alpha for colorectal neoplasms, with XBiotech Germany as the applicant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Neoplasms

Drugs mentioned

• human IgG1 monoclonal antibody specific for human interleukin-1 alpha (IL-1 alpha-targeting IgG1 monoclonal antibody)

Snippet

Status: Refused. Therapeutic area: Colorectal Neoplasms. MAH: XBiotech Germany GmbH. Decision date: 14/09/2017